Our COO, James Gaskell has shared his views on the industry, innovation and policy development at the second annual World Cannabis Congress, which took place on the 18th June in Canada. The World Cannabis Congress brings together global cannabis leaders, thought leaders, investors and researchers who exchange their ideas and opinions on the medicinal cannabis industry. Read more about the World Cannabis Congress here.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >